Hutchin Hill Capital’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$327K Sell
2,000
-49,500
-96% -$8.88M 0.09% 252
2017
Q3
$10.6M Buy
+51,500
New +$12M 0.4% 68
2016
Q3
Sell
-37,836
Closed -$8.74M 756
2016
Q2
$8.74M Sell
37,836
-144,586
-79% -$33.3M 0.29% 71
2016
Q1
$48.9M Buy
182,422
+179,722
+6,656% +$51.4M 1.43% 9
2015
Q4
$844K Sell
2,700
-86,300
-97% -$25.7M 0.02% 459
2015
Q3
$24.2M Sell
89,000
-31,000
-26% -$9.52M 0.92% 19
2015
Q2
$36.4M Sell
120,000
-108,100
-47% -$32.2M 0.94% 25
2015
Q1
$67.9M Buy
228,100
+117,800
+107% +$33.6M 1.88% 5
2014
Q4
$28.4M Sell
110,300
-17,201
-13% -$4.3M 1.01% 27
2014
Q3
$30.8M Buy
127,501
+4,501
+4% +$1.01M 1.16% 21
2014
Q2
$27.4M Sell
123,000
-69,800
-36% -$14.5M 1.25% 23
2014
Q1
$39.7M Buy
192,800
+130,300
+208% +$25.8M 2.06% 4
2013
Q4
$10.5M Buy
62,500
+35,000
+127% +$5.47M 0.72% 34
2013
Q3
$3.96M Sell
27,500
-246,300
-90% -$32.8M 0.36% 63
2013
Q2
$34.6M Buy
+273,800
New +$31M 3.55% 1

Other funds holding AGN

Hutchin Hill Capital's AGN Position: Q4 2017 in Review

Hutchin Hill Capital reduced its Allergan plc (AGN) stake by 96% in Q4 2017, selling an estimated $8.88M and leaving 2,000 shares worth $327K. The position accounts for 0.09% of the portfolio, ranked #252.

Hutchin Hill Capital first reported a position in AGN in Q2 2013 and has held it in 15 quarters since. The position peaked at $67.9M in Q1 2015. 1,048 funds tracked by Wall St. Rank hold AGN as of Q4 2017.

  • Hutchin Hill Capital held 2,000 shares of Allergan plc worth $327K as of Q4 2017.
  • Hutchin Hill Capital sold 49,500 Allergan plc shares in Q4 2017, an estimated $8.88M.
  • Allergan plc made up 0.09% of Hutchin Hill Capital's portfolio in Q4 2017, its #252 holding.
  • Hutchin Hill Capital first reported a position in Allergan plc in Q2 2013 and has held it in 15 quarters since.
  • Hutchin Hill Capital's Allergan plc position peaked at $67.9M in Q1 2015.
  • 1,048 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on Hutchin Hill Capital's 13F filing for Q4 2017, filed 12 Feb 2018.